Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
TILMICOSIN
Elanco Animal Health, Eli Lilly and Company Limited
QJ01FA91
TILMICOSIN
100
Premix for Med.Feedstuffs
POM
Porcine
Tilmicosin
Antibacterial
Authorised
1997-01-24
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Pulmotil G100 Premix for medicated feedingstuff 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Premix for medicated feedingstuff. A yellowish tan to reddish tan free flowing granular material. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs and rabbits 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs: Prevention and treatment of respiratory disease caused by _Actinobacillus pleuropneumoniae, Mycoplasma_ _hyopneumoniae, Pasteurella multocida _and other organisms sensitive to tilmicosin. Rabbits: Prevention and treatment of respiratory disease caused by _Pasteurella multocida _and _Bordetella_ _bronchiseptica, _susceptible to tilmicosin. 4.3 CONTRAINDICATIONS Horses or other E_quidae_, must not be allowed access to feeds containing tilmicosin. Horses fed with tilmicosin medicated feeds may present signs of toxicity with lethargy, anorexia, reduction of feed consumption, loose stools, colic, distension of the abdomen and death. Do not use in case of hypersensitivity to tilmicosin or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Under practical conditions, the management of respiratory disease outbreaks recognises that acutely ill animals are inappetant and require parenteral therapy. ACTIVE SUBSTANCE: Tilmicosin (as phosphate) 100 g/kg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 28/11/2013_ _CRN 7016168_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Inappropriate use of the product may increase the prevalence of bacteria resistant to tilmicosin and may decrease the effectiveness of treatment wit Прочитайте повний документ